<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/ivf-versus-surgery-endometriosis-infertility</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>IVF beat surgery for pregnancy in endometriosis, and the trial stopped early to say so</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/aspirin-recurrent-preterm-birth-placental-malperfusion</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Aspirin cut recurrent preterm birth, but only with prior placental vascular damage</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/tarlatamab-durvalumab-maintenance-es-sclc-dellphi-305</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Adding tarlatamab to maintenance nearly doubled survival in small-cell lung cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/prabitas-trifluridine-tipiracil-14-day-colorectal</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>A shorter trifluridine–tipiracil schedule matched the standard in bowel cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/niche-2-neoadjuvant-nivolumab-ipilimumab-dmmr-colon-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Immunotherapy before surgery kept every dMMR colon cancer patient alive at five years</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/mild-mt-thrombectomy-mild-large-vessel-stroke</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Thrombectomy beat drugs alone for mild large-vessel stroke in a China trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/late-mt-thrombectomy-24-72-hours-large-vessel-stroke</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Thrombectomy 24 to 72 hours after stroke improved outcomes in a China trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/divarasib-sotorasib-adagrasib-kras-g12c-nsclc-krascendo-1</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>A newer KRAS G12C drug beat the first two in a head-to-head lung cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-mandatory-cosmetics-recall-final-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>FDA finalises guidance on its mandatory cosmetics recall power</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-chemical-hazards-chapter-food-preventive-controls-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>FDA adds a chemical-hazards chapter to its food-safety guidance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-cadmium-action-levels-baby-food-draft-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>FDA proposes cadmium action levels for baby and toddler foods</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/re-program-internet-intervention-functional-seizures</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>A self-guided online programme cut functional seizures in a small trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/mebufotenin-intranasal-treatment-resistant-depression</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>A short-acting psychedelic nasal spray eased hard-to-treat depression</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/who-priority-pathogens-amr-mortality-32-year-gbd</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Global deaths from WHO&apos;s priority drug-resistant bacteria rose from 1990 to 2021</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/bundibugyo-ebola-kenya-nigeria-cross-border</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Bundibugyo Ebola crosses into Kenya and Nigeria as a vaccine trial begins in Congo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/family-health/phh-1v-adolescent-covid-booster</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>A protein-based COVID booster matched mRNA-primed teens&apos; immune response in a small trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/family-health/maternal-autoimmune-disease-offspring-type-1-diabetes</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Maternal autoimmune disease in pregnancy tied to higher type 1 diabetes risk in children</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/visionary-sibeprenlimab-iga-nephropathy-egfr-slope</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Sibeprenlimab held kidney function steady in IgA nephropathy&apos;s confirmatory trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/retatrutide-triumph-osa</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Retatrutide cut sleep-apnoea severity in two phase 3 trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/remibrutinib-remodel-relapsing-ms</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Remibrutinib beat an older oral drug on relapses in multiple sclerosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/rainier-povetacicept-iga-nephropathy-proteinuria</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Povetacicept slashed protein leakage in IgA nephropathy in an interim phase 3 look</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/overdose-acute-kidney-injury-mmwr-surveillance</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>One in three US drug-overdose hospitalisations involved acute kidney injury</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/origin-3-atacicept-iga-nephropathy-egfr</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Atacicept cut kidney-disease progression in IgA nephropathy, final trial shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/i-can-ravulizumab-iga-nephropathy-proteinuria</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Ravulizumab cut protein leakage in IgA nephropathy by targeting a different pathway</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/hibsago-bepirovirsen-hepatitis-b-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>FDA approves Hibsago, a first-of-its-kind antisense drug for hepatitis B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/enspryng-satralizumab-thyroid-eye-disease-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>FDA approves Enspryng for thyroid eye disease, given by injection</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/breztri-aerosphere-asthma-low-gwp-propellant-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>FDA clears Breztri for asthma and adds a lower-warming propellant</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/ayvakit-avapritinib-indolent-mastocytosis-dose-escalation</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-26</news:publication_date>
      <news:title>Ayvakit&apos;s label now lets some mastocytosis patients double the dose</news:title>
    </news:news>
  </url>
</urlset>